NASDAQ · Healthcare · Biotechnology
Alumis Inc.
ALMS
Alumis Inc. CEO Martin Babler · Market cap $830.7M.
$6.73
-0.04 · -0.59%
52w hi $31.3552w lo $4.28
Off 52w high 68.7%
62
NOTABLE
Current InsiderScore
Corp · 90d
3
3 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
26
0 strong · 26 notable
Analyst consensus
Strong Buy
Avg PT $31.63
Section 01
Recent Form 4 filings
47 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Sep 08 | Srinivas Akkaraju | Buy | 273,290 | $10.63 | +$2.90M | 62 | |
| Sep 08 | Srinivas Akkaraju | Buy | 273,291 | $10.63 | +$2.90M | 59 | |
| Sep 04 | Srinivas Akkaraju | Buy | 220,070 | $11.17 | +$2.46M | 56 | |
| Jan 09 | Srinivas Akkaraju | Buy | 588,235 | $17.00 | +$10.00M | 61 | |
| Jan 08 | James B. Tananbaum | Buy | 294,117 | $17.00 | +$5.00M | 73 | |
| Jan 08 | James B. Tananbaum | Buy | 117,647 | $17.00 | +$2.00M | 67 | |
| Jan 08 | Foresite Capital Management VI LLC | Buy | 294,117 | $17.00 | +$5.00M | 73 | |
| Jan 08 | Foresite Labs, LLC | Buy | 294,117 | $17.00 | +$5.00M | 73 | |
| Jan 08 | Foresite Capital Management VI LLC | Buy | 117,647 | $17.00 | +$2.00M | 67 | |
| Jan 08 | Foresite Labs, LLC | Buy | 117,647 | $17.00 | +$2.00M | 67 | |
| Dec 05 | Srinivas Akkaraju | Buy | 64,969 | $8.95 | +$581K | 48 | |
| Dec 05 | Srinivas Akkaraju | Buy | 70,028 | $10.01 | +$701K | 48 | |
| Dec 05 | Srinivas Akkaraju | Buy | 51,380 | $10.73 | +$551K | 39 | |
| Dec 04 | Srinivas Akkaraju | Buy | 66,027 | $8.18 | +$540K | 48 | |
| Dec 03 | Srinivas Akkaraju | Buy | 100,000 | $7.75 | +$775K | 51 | |
| Dec 02 | Srinivas Akkaraju | Buy | 96,000 | $7.55 | +$725K | 51 | |
| Dec 01 | Srinivas Akkaraju | Buy | 86,350 | $7.46 | +$644K | 51 | |
| Nov 28 | Srinivas Akkaraju | Buy | 38,702 | $7.64 | +$296K | 39 | |
| Nov 26 | Srinivas Akkaraju | Buy | 48,537 | $7.64 | +$371K | 39 | |
| Nov 21 | James B. Tananbaum | Buy | 72,212 | $7.38 | +$533K | 64 | |
| Nov 21 | Foresite Labs, LLC | Buy | 72,212 | $7.38 | +$533K | 64 | |
| Nov 21 | Foresite Capital Management VI LLC | Buy | 72,212 | $7.38 | +$533K | 64 | |
| Nov 20 | Srinivas Akkaraju | Buy | 125,743 | $7.20 | +$905K | 51 | |
| Nov 19 | Srinivas Akkaraju | Buy | 137,772 | $6.56 | +$904K | 70 | |
| Nov 19 | James B. Tananbaum | Buy | 190,500 | $6.56 | +$1.25M | 70 | |
| Nov 19 | Foresite Capital Management VI LLC | Buy | 190,500 | $6.56 | +$1.25M | 70 | |
| Nov 19 | Foresite Labs, LLC | Buy | 190,500 | $6.56 | +$1.25M | 70 | |
| Nov 18 | Srinivas Akkaraju | Buy | 102,652 | $6.05 | +$621K | 70 | |
| Nov 18 | James B. Tananbaum | Buy | 117,374 | $6.19 | +$727K | 67 | |
| Nov 18 | Foresite Capital Management VI LLC | Buy | 117,374 | $6.19 | +$727K | 67 | |
| Nov 18 | Foresite Labs, LLC | Buy | 117,374 | $6.19 | +$727K | 67 | |
| Nov 17 | James B. Tananbaum | Buy | 150,000 | $5.59 | +$839K | 67 | |
| Nov 17 | James B. Tananbaum | Buy | 50,000 | $5.60 | +$280K | 61 | |
| Nov 17 | Foresite Capital Management VI LLC | Buy | 50,000 | $5.60 | +$280K | 61 | |
| Nov 17 | Foresite Labs, LLC | Buy | 150,000 | $5.59 | +$839K | 67 | |
| Nov 17 | Foresite Capital Management VI LLC | Buy | 150,000 | $5.59 | +$839K | 67 | |
| Nov 17 | Foresite Labs, LLC | Buy | 50,000 | $5.60 | +$280K | 61 | |
| Nov 13 | Srinivas Akkaraju | Buy | 276,179 | $5.25 | +$1.45M | 61 | |
| May 06 | James B. Tananbaum | Buy | 20,000 | $4.34 | +$87K | 58 | |
| May 06 | Foresite Labs, LLC | Buy | 20,000 | $4.34 | +$87K | 58 | |
| May 06 | Foresite Capital Management VI LLC | Buy | 20,000 | $4.34 | +$87K | 58 | |
| May 05 | Srinivas Akkaraju | Buy | 138,368 | $4.58 | +$634K | 60 | |
| May 05 | Srinivas Akkaraju | Buy | 22,002 | $5.27 | +$116K | 57 | |
| May 02 | James B. Tananbaum | Buy | 25,000 | $4.62 | +$116K | 61 | |
| May 02 | Srinivas Akkaraju | Buy | 159,920 | $4.55 | +$728K | 60 | |
| May 02 | Foresite Capital Management VI LLC | Buy | 25,000 | $4.62 | +$116K | 61 | |
| May 02 | Foresite Labs, LLC | Buy | 25,000 | $4.62 | +$116K | 61 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct